Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer

Published:2015 Issue:1 Volume:13 Page:86
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:Journal of Translational Medicine

Author:

Mao Xiao,Zhang Luo,Huang Bin,Zhou Shi,Liao Jun,Chen Ling,Qiu Shao,Chen Jun

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-015-0438-8.pdf

Reference41 articles.

1. Current perspectives in bladder cancer management

2. The present and future burden of urinary bladder cancer in the world

3. The origins of bladder cancer

4. PHLPP: A Phosphatase that Directly Dephosphorylates Akt, Promotes Apoptosis, and Suppresses Tumor Growth

5. PHLPP and a Second Isoform, PHLPP2, Differentially Attenuate the Amplitude of Akt Signaling by Regulating Distinct Akt Isoforms

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder cancer: non-coding RNAs and exosomal non-coding RNAs;Functional & Integrative Genomics;2024-08-31

2. miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers;Technology in Cancer Research & Treatment;2024-01

3. Research Progress of ceRNA in Bladder Can-cer;Advances in Clinical Medicine;2024

4. MicroRNAs as master regulators of FOXO transcription factors in cancer management;Life Sciences;2023-05

5. Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators;Journal of Translational Medicine;2023-01-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3